Maudsley

Why are so many Australians taking antidepressants?

Retrieved on: 
Thursday, February 8, 2024

Around one in seven Australians take antidepressants; more than 3.5 million of us had them dispensed in 2021–22.

Key Points: 
  • Around one in seven Australians take antidepressants; more than 3.5 million of us had them dispensed in 2021–22.
  • Guidelines mostly recommend antidepressants for more severe depression and anxiety but not as first-line treatment for less severe depression.
  • So why are so many Australians taking antidepressants and why are prescriptions rising?

Enter the antidepressant ‘blockbusters’

  • In the 1990s, pharmaceutical companies heavily promoted new selective serotonin reuptake inhibitors (SSRI) antidepressants, including Prozac (fluoxetine), Zoloft (sertraline) and Lexapro (escitalopram).
  • These drugs were thought to be less dangerous in overdoses and seemed to have fewer side effects than the tricyclic antidepressants they replaced.
  • Pharmaceutical companies marketed SSRIs energetically and often exaggerated their benefits, including by paying “key opinion leaders” – high-status clinicians to promote them.

Why are antidepressants prescribed?

  • GPs also prescribe antidepressants to patients experiencing distress but who don’t have a psychiatric diagnosis.
  • Another, who cried when informed she had breast cancer, was immediately offered a prescription for antidepressants.
  • Most patients believe antidepressants restore a chemical imbalance that underpins depression.
  • Antidepressants are emotional (and sexual) numbing agents – sometimes sedating, sometimes energising.
  • Around half of users have impaired sexual function and for some, this sexual dysfunction persists after stopping antidepressants.

How long do people take antidepressants?

  • Around half of patients who start antidepressants don’t like them and stop within weeks.
  • Of those who do take them for months, many continue to use them indefinitely, often for many years.
  • Read more:
    Antidepressants can cause withdrawal symptoms – here’s what you need to know

We need to adjust how we view mental distress

  • Overprescribing antidepressants is a symptom of our lack of attention to the social determinants of mental health.
  • GPs also need to ensure they discuss with their patients the potential adverse effects of antidepressants, and when and how to safely stop them.
  • But the fundamental problem is social and can only be properly addressed by meaningfully addressing inequality and changing community attitudes to distress.


Jon Jureidini receives research funding from MMRF. He is affiliated with Critical Psychiatry Network Australasia.

Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center

Retrieved on: 
Wednesday, November 15, 2023

The ongoing phase 3 program is the largest randomized, controlled, double-blind psilocybin treatment clinical program ever conducted and follows promising results from Compass’s phase 2b study of COMP360 psilocybin treatment.

Key Points: 
  • The ongoing phase 3 program is the largest randomized, controlled, double-blind psilocybin treatment clinical program ever conducted and follows promising results from Compass’s phase 2b study of COMP360 psilocybin treatment.
  • The phase 3 program consists of two pivotal trials (COMP 005 and COMP 006), and each trial has an integrated, long-term outcomes component.
  • COMP 006 will take place in the UK and globally and will study three dose arms of COMP360 (25mg, 10mg and 1mg).
  • COMP 005 is a US-based trial examining the effect of a single 25mg dose of COMP360 psilocybin, compared with placebo.

DOVE TAKES ACTION AGAINST ONE OF THE BIGGEST THREATS TO KIDS' MENTAL HEALTH TODAY

Retrieved on: 
Tuesday, May 9, 2023

Over 8 in 10 youth mental health specialists say social media is fuelling a mental health crisis among young people.

Key Points: 
  • Over 8 in 10 youth mental health specialists say social media is fuelling a mental health crisis among young people.
  • Alongside singer/songwriter Self Esteem, Dove is partnering with Parenting Mental Health, Global Action Plan, 5Rights, Girlguiding to take action to support young people's mental health.
  • Dove is bringing together NGO partners Parenting Mental Health, Global Action Plan, 5Rights, and Girlguiding to provide access to mental health resources for young people, and work to make social media safer for kids.
  • The new 2023 Dove Self-Esteem Project Research for Kids Online Safety found:
    Over 8 in 10 youth mental health specialists say social media is fuelling a mental health crisis among young people.

Totara supports 350,000 NHS staff through COVID-19 with Think Learning

Retrieved on: 
Wednesday, September 15, 2021

SAN FRANCISCO, Sep. 15, 2021 /PRNewswire-PRWeb/ -- Think Learning is the leading Totara Learn supplier to the UK healthcare sector with around 25% (350,000 employees) of NHS employees in England now accessing a Totara learning platform supported by Think Learning.

Key Points: 
  • SAN FRANCISCO, Sep. 15, 2021 /PRNewswire-PRWeb/ -- Think Learning is the leading Totara Learn supplier to the UK healthcare sector with around 25% (350,000 employees) of NHS employees in England now accessing a Totara learning platform supported by Think Learning.
  • The Totara platform has allowed the NHS to rapidly onboard thousands of volunteers and medical staff returning to work to deliver the vaccination program during 2021.
  • Maged Fahmy, Chief Commercial Officer at Totara, said: "We are extremely proud of the fact that so many NHS Trusts chose Totara as their learning platform of choice throughout the pandemic.
  • Think Learning is a fast-growing UK Totara Partner, providing platform and consultancy services in a range of sectors.